Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

FAS promoter polymorphisms and cancer risk: a meta-analysis based on 34 case-control studies.

Carcinogenesis - 1 Mar 2009

Zhang Zhizhong, Xue Hengchuan, Gong Weida, Wang Meilin, Yuan Lin, Han Suping, Zhang Zhengdong

Abstract excerpt

FAS is a cell surface receptor involved in apoptotic signal transmission and plays important roles in the etiology of cancer. The -1377G>A and -670A>G polymorphisms of the FAS gene influence the FAS transcription and have been implicated in cancer risk. However, the results from the published studies on the association between these two FAS polymorphisms and cancer risk are conflicting. To derive a more precise...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Case-Control Studies
Share to fas Receptor
Share to FAS gene

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Genetic Predisposition to Disease

Share to Neoplasms

Share to Polymorphism, Genetic

Share to Promoter Regions, Genetic

Share to Smoking

Source

Identifiers

PMID: 19168581
DOI: 10.1093/carcin/bgp016

Genes

FAS

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

FAS promoter polymorphisms and cancer risk: a meta-analysis based on 34 case-control studies.PMID 19168581Read ↗

FAS-1377 G/A (rs2234767) polymorphism and cancer susceptibility: a meta-analysis of 17,858 cases and 24,311 controls.Semantic proximity Read ↗

Association of the polymorphisms in the Fas/FasL promoter regions with cancer susceptibility: a systematic review and meta-analysis of 52 studies.Semantic proximity Read ↗

Association of Fas -1377 G/A polymorphism with susceptibility to cancer.Semantic proximity Read ↗

FAS-1377 A/G polymorphism in breast cancer: a meta-analysis.Semantic proximity Read ↗

Association between FAS 1377G>A polymorphism and breast cancer susceptibility: a meta-analysis.Semantic proximity Read ↗

Association between the FAS rs2234767G/A polymorphism and cancer risk: a systematic review and meta-analysis.Semantic proximity Read ↗

Quantitative assessment of the association between three polymorphisms in FAS and FASL gene and breast cancer risk.Semantic proximity Read ↗

Significant association among the Fas -670 A/G (rs1800682) polymorphism and esophageal cancer, hepatocellular carcinoma, and prostate cancer susceptibility: a meta-analysis.Semantic proximity Read ↗

Correlation between FAS single nucleotide polymorphisms and breast carcinoma susceptibility in Asia.Semantic proximity Read ↗

FAS -1,377 G/A polymorphism is associated with cancer susceptibility: evidence from 10,564 cases and 12,075 controls.Semantic proximity Read ↗

The FAS ligand promoter polymorphism, rs763110 (-844C>T), contributes to cancer susceptibility: evidence from 19 case-control studies.Semantic proximity Read ↗

FASL rs763110 polymorphism contributes to cancer risk: an updated meta-analysis involving 43,295 subjects.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.